Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results


Por: Delgado, J, Espinet, B, Oliveira, AC, Abrisqueta, P, de la Serna, J, Collado, R, Loscertales, J, Lopez, M, Hernandez-Rivas, JA, Ferra, C, Ramirez, A, Roncero, JM, Lopez, C, Aventin, A, Puiggros, A, Abella, E, Carbonell, F, Costa, D, Carrio, A, Gonzalez, M

Publicada: 1 abr 2012
Resumen:
Patients with chronic lymphocytic leukaemia (CLL) whose tumour cells harbour a 17p deletion (17p-) are universally considered to have a poor prognosis. The deletion can be detected at diagnosis or during the evolution of the disease, particularly in patients who have received chemotherapy. We sought to evaluate the natural history of patients with 17p- CLL, identify predictive factors within this prognostic subgroup, and evaluate the results of different therapeutic approaches. Data from 294 patients with 17p- CLL followed up at 20 different institutions was retrospectively collected and analysed. Median age was 68 (range 2798) years at the time of fluorescence in situ hybridization analysis. After 17p- documentation, 52% received treatment, achieving an overall response rate of 50%. Median overall survival was 41 months, and was significantly shorter in patients with elevated beta2-microglobulin concentration (P < 00 001), B symptoms ( P = 0 016), higher percentage of cells with deletion ( P < 0 001), and acquired deletions ( P = 0 012). These findings suggest that patients with 17p- CLL have a variable prognosis that can be refined using simple clinical and laboratory features, including 17p- clone size, beta2- microglobulin concentration, presence of B symptoms and type of deletion ( de novo versus acquired).

Filiaciones:
Delgado, J:
 Univ Barcelona, Dept Haematol, Inst Haematol & Oncol, Hosp Clin,IDIBAPS, E-08036 Barcelona, Spain

 Hosp Santa Creu & Sant Pau, Barcelona, Spain

Espinet, B:
 Hosp Mar, Barcelona, Spain

Oliveira, AC:
 Hosp Duran & Reynals, Barcelona, Spain

Abrisqueta, P:
 Hosp Gen Valle Hebron, Barcelona, Spain

de la Serna, J:
 Hosp 12 Octubre, E-28041 Madrid, Spain

Collado, R:
 Gen Hosp, Valencia, Spain

Loscertales, J:
 Hosp La Princesa, Madrid, Spain

Lopez, M:
 Hosp Principe Asturias, Madrid, Spain

Hernandez-Rivas, JA:
 Hosp Infanta Leonor, Madrid, Spain

Ferra, C:
 Hosp Badalona Germans Trias & Pujol, Badalona, Spain

Ramirez, A:
 Univ Oviedo, Hosp Cent Asturias, E-33080 Oviedo, Spain

Roncero, JM:
 Hosp Josep Trueta, Girona, Spain

Aventin, A:
 Hosp Santa Creu & Sant Pau, Barcelona, Spain

Puiggros, A:
 Hosp Mar, Barcelona, Spain

Abella, E:
 Hosp Mar, Barcelona, Spain

Carbonell, F:
 Gen Hosp, Valencia, Spain

Gonzalez, M:
 Hosp Clin Salamanca, Salamanca, Spain
ISSN: 00071048





BRITISH JOURNAL OF HAEMATOLOGY
Editorial
WILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Reino Unido
Tipo de documento: Article
Volumen: 157 Número: 1
Páginas: 67-74
WOS Id: 000301436700009
ID de PubMed: 22224845

MÉTRICAS